This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Franchini M, Favaloro EJ, Targher G, Lippi G (2012) ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 49:137–149
Wu O, Bayoumi N, Vickers MA, Clark P (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 6:2–69
Dentali F, Sironi AP, Ageno W et al (2012) Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 38:535–548
Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695
Dentali F, Sironi AP, Ageno W et al (2012) Relationship between ABO blood group and hemorrhage: a systematic review and meta-analysis. Semin Thromb Hemost [Epub ahead of print]
Garcia AA, van der Heijden JF, Meijers JCM, Rosendaal FR, Reitsma PH (2006) The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. J Thromb Haemost 4:1418–1420
Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A; for the SPIRIT Study Group (2007) Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol 254:1660–1665
Franchini M, Crestani S, Frattini F, Mengoli C, Bonfanti C (2012) Relationship between ABO blood group and bleeding complications in orally anticoagulated patients. J Thromb Haemost 10:1688–1691
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214
Franchini M, Crestani S, Rossi C et al (2012) O blood group and the risk of major bleeding: a single-center survey. J Thromb Thrombolysis [Epub ahead of print]
Franchini M, Mannucci PM (2008) Von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemost 34:663–669
About this article
Cite this article
Franchini, M., Rossi, C., Mengoli, C. et al. O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients. J Thromb Thrombolysis 36, 358–360 (2013). https://doi.org/10.1007/s11239-012-0855-y
- Blood Group
- Oral Anticoagulant Therapy
- Anticoagulated Patient
- Coagulation Factor VIII
- Bleeding Risk Factor